Close
Smartlab Europe
Inizio Ignite

Press Releases

CluePoints Launch Post-COVID Trial Assurance Solution

CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and, CROs. The pandemic has been the...

Roches Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults and children

Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental...

Drug delivery innovation across Europe improves for third consecutive year ahead of Pharmapack Europe

Ahead of Pharmapack Europe 2021 (Paris Expo, Porte de Versailles, 13-14 October) – the returning European event dedicated to drug packaging and delivery – there has been a huge swathe of innovation across the industry, with more than 53...

Qatar Airways Cargo Offers its Customers Envirotainers Innovative Releye RLP containerfor Pharma Transport

Qatar Airways Cargo announces the approval of Envirotainer’s latest innovation – The Releye® RLP container. With the newest addition to its range of temperature-controlled containers, the airline now offers 16 temperature-controlled container leasing options for life science and health...

Emirates SkyCargo to integrate Envirotainer Releye RLP container into its cool chain portfolio

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that Emirates SkyCargo, the freight division of Dubai-based Emirates airline, has approved the use of the Environtainer Releye® RLP container on its aircraft...

Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

Cryoport, Inc. , a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that Cellenkos®, Inc., a privately held, clinical-stage biotechnology company, has selected Cryoport to provide a staged, on-demand, logistics solution for COVID-19 therapy...

Bristol Myers Squibb Receives EU Approval for Onureg as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

Bristol Myers Squibb announced that the European Commission (EC) has granted full Marketing Authorization for Onureg® (azacitidine tablets) as a maintenance therapy in adult patients with acute myeloid leukemia (AML) who achieved complete remission (CR) or complete remission with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »